Drug-associated non-pyrogenic hyperthermia

A narrative review

Koen Sebastiaan Bongers, Mohammed S. Salahudeen, Gregory M. Peterson

Research output: Contribution to journalArticle

Abstract

Purpose: Hyperthermia occurs when heat accumulation surpasses the body’s ability for heat dissipation. Many drugs may affect thermoregulation. This narrative review aimed to provide an overview of the current literature concerning reports of drug-associated non-pyrogenic hyperthermia. Methods: A comprehensive search was performed across 5 databases covering the period of inception to March 2019, for publications that reported hyperthermia associated with drug use. Studies that reported potential drug association with hyperthermia due to altered thermoregulatory mechanisms were included. Case reports of less than 3 cases were excluded, as well as hyperthermia due to other causes, such as hypersensitivity, malignant hyperthermia and neuroleptic malignant syndrome. The primary outcomes of interest were hospitalisation and mortality. Results: The literature search initially identified a total of 2609 records. Based on full-text analysis, 11 articles met the inclusion criteria, of which there were 5 case-control studies, 2 case series and 4 retrospective analyses. Studies reported heat-related hospitalisations or emergency department presentations associated with the use of psychotropics (antipsychotics, antidepressants and anxiolytics), anticholinergics, antihistamines, diuretics, cardiovascular agents, non-steroidal anti-inflammatory drugs and anticoagulants. Psychotropic drugs were reported to be associated with increased heat-related mortality, other than through neuroleptic malignant syndrome, but findings varied among the studies. Conclusion: Given the relative lack of publications, more research is necessary to study specific effects of drugs on body temperature and the likelihood of inducing non-pyrogenic hyperthermia. In particular, psychotropics, anticholinergics, diuretics and cardiovascular agents are of interest for future studies.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalEuropean Journal of Clinical Pharmacology
DOIs
Publication statusE-pub ahead of print - 23 Oct 2019

Fingerprint

Fever
Hot Temperature
Pharmaceutical Preparations
Neuroleptic Malignant Syndrome
Cardiovascular Agents
Cholinergic Antagonists
Diuretics
Publications
Hospitalization
Malignant Hyperthermia
Mortality
Body Temperature Regulation
Histamine Antagonists
Psychotropic Drugs
Anti-Anxiety Agents
Body Temperature
Anticoagulants
Antidepressive Agents
Antipsychotic Agents
Case-Control Studies

Cite this

Bongers, Koen Sebastiaan ; Salahudeen, Mohammed S. ; Peterson, Gregory M. / Drug-associated non-pyrogenic hyperthermia : A narrative review. In: European Journal of Clinical Pharmacology. 2019 ; pp. 1-8.
@article{edd983f93df44ee7a45ec21036dc458c,
title = "Drug-associated non-pyrogenic hyperthermia: A narrative review",
abstract = "Purpose: Hyperthermia occurs when heat accumulation surpasses the body’s ability for heat dissipation. Many drugs may affect thermoregulation. This narrative review aimed to provide an overview of the current literature concerning reports of drug-associated non-pyrogenic hyperthermia. Methods: A comprehensive search was performed across 5 databases covering the period of inception to March 2019, for publications that reported hyperthermia associated with drug use. Studies that reported potential drug association with hyperthermia due to altered thermoregulatory mechanisms were included. Case reports of less than 3 cases were excluded, as well as hyperthermia due to other causes, such as hypersensitivity, malignant hyperthermia and neuroleptic malignant syndrome. The primary outcomes of interest were hospitalisation and mortality. Results: The literature search initially identified a total of 2609 records. Based on full-text analysis, 11 articles met the inclusion criteria, of which there were 5 case-control studies, 2 case series and 4 retrospective analyses. Studies reported heat-related hospitalisations or emergency department presentations associated with the use of psychotropics (antipsychotics, antidepressants and anxiolytics), anticholinergics, antihistamines, diuretics, cardiovascular agents, non-steroidal anti-inflammatory drugs and anticoagulants. Psychotropic drugs were reported to be associated with increased heat-related mortality, other than through neuroleptic malignant syndrome, but findings varied among the studies. Conclusion: Given the relative lack of publications, more research is necessary to study specific effects of drugs on body temperature and the likelihood of inducing non-pyrogenic hyperthermia. In particular, psychotropics, anticholinergics, diuretics and cardiovascular agents are of interest for future studies.",
keywords = "Adverse drug reactions, Drug-associated, Heat exhaustion, Heat stroke, Hospitalisation, Hyperthermia, Non-pyrogenic, Thermoregulation",
author = "Bongers, {Koen Sebastiaan} and Salahudeen, {Mohammed S.} and Peterson, {Gregory M.}",
year = "2019",
month = "10",
day = "23",
doi = "10.1007/s00228-019-02763-5",
language = "English",
pages = "1--8",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",

}

Drug-associated non-pyrogenic hyperthermia : A narrative review. / Bongers, Koen Sebastiaan; Salahudeen, Mohammed S.; Peterson, Gregory M.

In: European Journal of Clinical Pharmacology, 23.10.2019, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug-associated non-pyrogenic hyperthermia

T2 - A narrative review

AU - Bongers, Koen Sebastiaan

AU - Salahudeen, Mohammed S.

AU - Peterson, Gregory M.

PY - 2019/10/23

Y1 - 2019/10/23

N2 - Purpose: Hyperthermia occurs when heat accumulation surpasses the body’s ability for heat dissipation. Many drugs may affect thermoregulation. This narrative review aimed to provide an overview of the current literature concerning reports of drug-associated non-pyrogenic hyperthermia. Methods: A comprehensive search was performed across 5 databases covering the period of inception to March 2019, for publications that reported hyperthermia associated with drug use. Studies that reported potential drug association with hyperthermia due to altered thermoregulatory mechanisms were included. Case reports of less than 3 cases were excluded, as well as hyperthermia due to other causes, such as hypersensitivity, malignant hyperthermia and neuroleptic malignant syndrome. The primary outcomes of interest were hospitalisation and mortality. Results: The literature search initially identified a total of 2609 records. Based on full-text analysis, 11 articles met the inclusion criteria, of which there were 5 case-control studies, 2 case series and 4 retrospective analyses. Studies reported heat-related hospitalisations or emergency department presentations associated with the use of psychotropics (antipsychotics, antidepressants and anxiolytics), anticholinergics, antihistamines, diuretics, cardiovascular agents, non-steroidal anti-inflammatory drugs and anticoagulants. Psychotropic drugs were reported to be associated with increased heat-related mortality, other than through neuroleptic malignant syndrome, but findings varied among the studies. Conclusion: Given the relative lack of publications, more research is necessary to study specific effects of drugs on body temperature and the likelihood of inducing non-pyrogenic hyperthermia. In particular, psychotropics, anticholinergics, diuretics and cardiovascular agents are of interest for future studies.

AB - Purpose: Hyperthermia occurs when heat accumulation surpasses the body’s ability for heat dissipation. Many drugs may affect thermoregulation. This narrative review aimed to provide an overview of the current literature concerning reports of drug-associated non-pyrogenic hyperthermia. Methods: A comprehensive search was performed across 5 databases covering the period of inception to March 2019, for publications that reported hyperthermia associated with drug use. Studies that reported potential drug association with hyperthermia due to altered thermoregulatory mechanisms were included. Case reports of less than 3 cases were excluded, as well as hyperthermia due to other causes, such as hypersensitivity, malignant hyperthermia and neuroleptic malignant syndrome. The primary outcomes of interest were hospitalisation and mortality. Results: The literature search initially identified a total of 2609 records. Based on full-text analysis, 11 articles met the inclusion criteria, of which there were 5 case-control studies, 2 case series and 4 retrospective analyses. Studies reported heat-related hospitalisations or emergency department presentations associated with the use of psychotropics (antipsychotics, antidepressants and anxiolytics), anticholinergics, antihistamines, diuretics, cardiovascular agents, non-steroidal anti-inflammatory drugs and anticoagulants. Psychotropic drugs were reported to be associated with increased heat-related mortality, other than through neuroleptic malignant syndrome, but findings varied among the studies. Conclusion: Given the relative lack of publications, more research is necessary to study specific effects of drugs on body temperature and the likelihood of inducing non-pyrogenic hyperthermia. In particular, psychotropics, anticholinergics, diuretics and cardiovascular agents are of interest for future studies.

KW - Adverse drug reactions

KW - Drug-associated

KW - Heat exhaustion

KW - Heat stroke

KW - Hospitalisation

KW - Hyperthermia

KW - Non-pyrogenic

KW - Thermoregulation

UR - http://www.scopus.com/inward/record.url?scp=85074034944&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/drugassociated-nonpyrogenic-hyperthermia-narrative-review

U2 - 10.1007/s00228-019-02763-5

DO - 10.1007/s00228-019-02763-5

M3 - Article

SP - 1

EP - 8

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

ER -